CBU
NUVB icon

CIBC Bancorp USA’s Nuvation Bio NUVB Stock Holding History

CIBC Bancorp USA’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.4K Buy
+13,146
New +$73.2K ﹤0.01% 1715
2025
Q3 		$98.4K Buy
+26,604
New +$72.5K ﹤0.01% 1355

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIBC Bancorp USA's NUVB Position: Q1 2026 in Review

CIBC Bancorp USA opened a new position in Nuvation Bio (NUVB) in Q1 2026: 13,146 shares worth $56.4K. The stake represents ﹤0.01% of the portfolio and ranks #1715 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in NUVB as recently as Q3 2025.

CIBC Bancorp USA first reported a position in NUVB in Q3 2025 and has held it in 2 quarters since. The position peaked at $98.4K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • CIBC Bancorp USA held 13,146 shares of Nuvation Bio worth $56.4K as of Q1 2026.
  • Nuvation Bio was a new CIBC Bancorp USA position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q1 2026, its #1715 holding.
  • CIBC Bancorp USA first reported a position in Nuvation Bio in Q3 2025 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Nuvation Bio position peaked at $98.4K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on CIBC Bancorp USA's 13F filing for Q1 2026, filed 12 May 2026.